Prospective observational study of acute exacerbation in interstitial lung diseases for new diagnostic criteria

Prospective observational study of acute exacerbation in interstitial lung diseases for new diagnostic criteria - Prospective observational study of acute exacerbation in interstitial lung diseases (AEILD Study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027844

Enrollment

800

Registered

2017-07-01

Start date

2017-06-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute deterioration of interstitial lung diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) idiopathic interstitial pneumonias (IIPs) and interstitial lung diseases (ILDs) other than IIPs including chronic hypersensitivity pneumonia, collagen vascular diseases-ILDs and asbestosis 2) Cases that deteriorated with deterioration of dyspnea and newly developed pulmonary shadows.

Exclusion criteria

Exclusion criteria: 1) Survival is supposed to be less than 3 months due to complications of ILDs 2) Cases that researchers have determined to be improper for inclusion

Design outcomes

Primary

Measure	Time frame
Clinical factors to determine 3-month survival of acute deterioration in interstitial lung diseases	—

Secondary

Measure	Time frame
1)Clinical factors to determine 1-year survival of acute deterioration in interstitial lung diseases 2)Change of clinical parameters after acute deterioration of ILDs 3)Therapy 4)Cause of death 5)Adverse events 6)Efficacy of present diagnostic criteria of acute exacerbation 7)Comparison of present diagnostic criterion of acute exacerbation 8)To make a new diagnostic criteria of acute exacerbation of ILDs	—

Measure

Time frame

1)Clinical factors to determine 1-year survival of acute deterioration in interstitial lung diseases 2)Change of clinical parameters after acute deterioration of ILDs 3)Therapy 4)Cause of death 5)Adverse events 6)Efficacy of present diagnostic criteria of acute exacerbation 7)Comparison of present diagnostic criterion of acute exacerbation 8)To make a new diagnostic criteria of acute exacerbation of ILDs

—

Countries

Japan

Contacts

Public ContactYuki Matsui

NHO Kinki-Chuo Chest Medical Center Clinical Research Center

matsui.yuki.yx@mail.hosp.go.jp072-252-3021

Outcome results